1. Home
  2. CHRO vs ZCMD Comparison

CHRO vs ZCMD Comparison

Compare CHRO & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • ZCMD
  • Stock Information
  • Founded
  • CHRO 2002
  • ZCMD 2012
  • Country
  • CHRO United States
  • ZCMD China
  • Employees
  • CHRO N/A
  • ZCMD N/A
  • Industry
  • CHRO
  • ZCMD Other Consumer Services
  • Sector
  • CHRO
  • ZCMD Real Estate
  • Exchange
  • CHRO Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • CHRO 3.9M
  • ZCMD 3.4M
  • IPO Year
  • CHRO 2024
  • ZCMD 2020
  • Fundamental
  • Price
  • CHRO $0.66
  • ZCMD $1.20
  • Analyst Decision
  • CHRO Strong Buy
  • ZCMD
  • Analyst Count
  • CHRO 1
  • ZCMD 0
  • Target Price
  • CHRO N/A
  • ZCMD N/A
  • AVG Volume (30 Days)
  • CHRO 100.6K
  • ZCMD 15.1K
  • Earning Date
  • CHRO 11-13-2024
  • ZCMD 01-01-0001
  • Dividend Yield
  • CHRO N/A
  • ZCMD N/A
  • EPS Growth
  • CHRO N/A
  • ZCMD N/A
  • EPS
  • CHRO N/A
  • ZCMD N/A
  • Revenue
  • CHRO N/A
  • ZCMD $17,406,104.00
  • Revenue This Year
  • CHRO N/A
  • ZCMD N/A
  • Revenue Next Year
  • CHRO N/A
  • ZCMD N/A
  • P/E Ratio
  • CHRO N/A
  • ZCMD N/A
  • Revenue Growth
  • CHRO N/A
  • ZCMD 1.01
  • 52 Week Low
  • CHRO $0.52
  • ZCMD $1.00
  • 52 Week High
  • CHRO $6.00
  • ZCMD $9.90
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 48.22
  • ZCMD 36.47
  • Support Level
  • CHRO $0.63
  • ZCMD $1.17
  • Resistance Level
  • CHRO $0.69
  • ZCMD $1.28
  • Average True Range (ATR)
  • CHRO 0.06
  • ZCMD 0.09
  • MACD
  • CHRO 0.01
  • ZCMD -0.00
  • Stochastic Oscillator
  • CHRO 52.55
  • ZCMD 6.25

About CHRO Chromocell Therapeutics Corporation

Chromocell Therapeutics Corp is a clinical-stage biotechnology company focused on developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain and other associated medical conditions. The company's initial clinical focus is to selectively target the sodium ion-channel known as NaV1.7 for the treatment of various types of chronic neuropathic pain and eye pain. The Company's portfolio also includes pre-clinical work on other sodium channel receptor subtypes, and the company intends to explore these and other compounds for the treatment of additional pain indications.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

Share on Social Networks: